Research Archive — Page 133 of 194

A scientist in a white lab coat points to an image on a tablet while speaking with a suited visitor in a laboratory.
January 29, 2015

Core facilities key driver of VUMC research gains

During the past five years, Vanderbilt University Medical Center has become a leader in “personalized medicine,” the use of genomic information to individualize patient care.

Rows of labeled blood collection tubes with purple caps arranged in a laboratory storage rack.
January 29, 2015

Consent process for BioVU participation updated

As of last week, Vanderbilt has updated the process used to facilitate patient participation in BioVU, the Medical Center’s DNA repository.

A doctor in a white coat speaks with a seated male patient and a woman in a medical examination room; another woman sits between them.
January 29, 2015

New therapy options enhance prostate cancer treatment

Vanderbilt-Ingram Cancer Center (VICC) patient William Ostman smiled while gazing into a camera lens and declared, “I am a prostate cancer survivor.”

Two adults perform an overhead yoga stretch in a clinical room beside a posture-assessment chart.
January 29, 2015

VUSN study tracking yoga therapy for cancer patients

Cancer is bad enough. But cancer patients who receive surgery, radiation and chemotherapy may suffer from side effects that run from irritating to crippling — problems that are postural, musculoskeletal and respiratory, along with lowered self-esteem.

Fluorescence microscopy image showing pancreatic tissue structures against a black background, with cells highlighted in blue, red, and green.
January 29, 2015

Grant bolsters pancreatic cancer drug discovery efforts

The Lustgarten Foundation has awarded a $1.5 million Research Investigator Grant to Stephen Fesik, Ph.D., professor of Biochemistry, Pharmacology and Chemistry, for research designed to discover new drugs for the treatment of pancreatic cancer.

puzzel pieces, autism
January 29, 2015

Altered dopamine signaling may offer a clue to autism

Newly discovered genetic variations linked to autism spectrum disorder (ASD) disrupt the function of the dopamine transporter, suggesting that altered dopamine signaling contributes to this common developmental condition, according to a Vanderbilt University-led research team.